PharmaVOICE recently published a cover article in its February 2012 issue titled “Safety and Pharmacovigilance:
In the article, Caubel states, “The … challenge is the emergence of diversified and non-conventional sources of safety information—
A team of Millennium experts will address this very challenge of integrating and utilizing social media into the overall drug safety plan. Veronique Kugener, MD, MSc, MBA, Vice President, Pharmacovigilance and Risk Management for Millennium: The Takeda Oncology Company, will lead the session with key aspects including:
• Leveraging platforms such as YouTube, LinkedIn, twitter and blogging to help promote transparency and education
• Dissecting the FDA’s draft guidelines regarding social media for the pharmaceutical industry and the potential impact
• Discussing the future of Adverse Event Reporting (AER) in a digital age with more patients becoming engaged and vocal through numerous platforms
• Weighing the benefits and legal ramifications of launching an open forum where patients can report positive experiences or adverse reactions
Additional Millennium speakers on the panel include Chris Sanders, Manager, Pharmacovigilance & Risk Management and Pat Connelly, Associate Director, Digital Strategy and Communications.
marcus evans invites Drug Safety, Product Safety and REMS professionals to join in this cutting-edge, peer-to-peer conference that examines best practices in the Pharmacovigilance industry. In addition to two days of conference sessions, attendees will have extensive networking opportunities with their peers.
For more information on this conference or to get a complete list of speakers, sessions or past attendees, visit http://www.marcusevansch.com/
# # #
Marcus evans conferences annually produce over 2,000 high quality events designed to provide key strategic business information, best practice and networking opportunities for senior industry decision-makers.